MBX Biosciences, Inc. (MBX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2023: -$31.98M2024: -$54.68M2025: -$79.95M-$79.95M
2023Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$79.95M-46.2%
2024-$54.68M-71.0%
2023-$31.98M